Shopping Cart
- Remove All
Your shopping cart is currently empty
JNJ-10311795
🥰Excellent
Catalog No. T27660Cas No. 518062-14-1
Alias RWJ-355871, RWJ355871, JNJ10311795
JNJ-10311795 (RWJ-355871) is a potent dual inhibitor of neutrophil elastase (Ki = 38 nM) and mast cell chymase (Ki = 2.3 nM) with significant anti-inflammatory activity, useful for studying pneumonia.
JNJ-10311795
🥰Excellent
Purity: 99.19%
Catalog No. T27660Alias RWJ-355871, RWJ355871, JNJ10311795Cas No. 518062-14-1
JNJ-10311795 (RWJ-355871) is a potent dual inhibitor of neutrophil elastase (Ki = 38 nM) and mast cell chymase (Ki = 2.3 nM) with significant anti-inflammatory activity, useful for studying pneumonia.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $293 | In Stock | |
| 5 mg | $722 | In Stock | |
| 10 mg | $987 | In Stock | |
| 25 mg | $1,520 | In Stock | |
| 50 mg | $1,980 | In Stock |
Bulk & Custom
Add to Cart
Questions
View MoreInhibitors Related to "JNJ-10311795"
Papain
T195039001-73-4
Papain, a cysteine protease of the peptidase C1 family, is utilized in the food, pharmaceutical, textile, and cosmetic industries.
- $45
Size
QTY
2-Aminoethanethiol
β-Mercaptoethylamine, β-MEA, Cysteamine, 2-Mercaptoethylamine
T108060-23-1
2-Aminoethanethiol (Cysteamine) is a Cystine Depleting Agent. The mechanism of action of cysteamine is as a Cystine Disulfide Reduction.
- $45
Size
QTY
(S)-(+)-Ibuprofen
Dexibuprofen, (S)-Ibuprofen
T044851146-56-6
(S)-(+)-Ibuprofen (Dexibuprofen) , is a non-steroidal anti-inflammatory drug (NSAID), inhibiting cyclooxygenase (COX).
- $35
Size
QTY
N-Ethylmaleimide
Cited
NEM, Ethylmaleimide, 1-Ethyl-1H-pyrrole-2,5-dione
T3088128-53-0
N-Ethylmaleimide (NEM) is a reagent for alkylation of free sulfhydryl groups, a cysteine protease inhibitor used in experimental biochemistry. N-Ethylmaleimide is also a deubiquitinating enzyme inhibitor that specifically inhibits phosphate transport in mitochondria.
- $39
Size
QTY
CitedAloxistatin Cited
Loxistatin, E64d, E64c ethyl ester
T604088321-09-9
Aloxistatin (E64d) is an inhibitor of cysteine protease with blood platelet aggregation inhibiting activity. Aloxistatin is an irreversible, membrane-permeable inhibitor of lysosomal and cytosolic cysteine proteases with the ability to inhibit calpain activity in intact platelets.
- $36
Size
QTY
CitedPMSF Cited
Phenylmethylsulfonyl fluoride, Benzylsulfonyl fluoride
T0789329-98-6
Phenylmethanesulfonyl fluoride (PMSF (Phenylmethylsulfonyl fluoride)) is an enzyme inhibitor that inactivates IRC-50 arvin, subtilisin, and the fatty acid synthetase complex.
- $33
Size
QTY
CitedE-64 Cited
Proteinase inhibitor E 64, E64, E 64
T603766701-25-5
E-64 (Proteinase inhibitor E 64) is an irreversible and specific inhibitor of cysteine proteases, exhibiting an IC50 of 9 nM for papain.
- $31
Size
QTY
CitedKGP94
KGP-94, KGP 94
T277301131456-28-4
KGP94 is an inhibitor of cysteine protease Cathepsin L(CTSL).
- $115
Size
QTY
2-Cyanopyrimidine
2-cyano-Pyrimidine
T745114080-23-0
2-Cyanopyrimidine (m-Hydroxyphenylpropionic acid) is inhibitor of cathepsin K(IC50 : 170 nM)
- $29
Size
QTY
Esomeprazole
T20626119141-88-7
Esomeprazole is the S-isomer of omeprazole, inhibits the lysosomal cysteine protease legumain to prevent cancer metastasis. Esomeprazole is a proton pump inhibitors (PPI).
- $57
Size
QTY
Z-Lys-OH
T658682212-75-1
Z-Lys-OH is a competitive inhibitor of papain, a lysine derivative.
- $29
Size
QTY
Leupeptin Hemisulfate
Cited
T6564103476-89-7
Leupeptin hemisulfate is a protease inhibitor with cell membrane-permeable, reversible, competitive, and oral activities. Leupeptin hemisulfate inhibits the activity of Cathepsin B, Cathepsin H, and Cathepsin L, and blocks fusion of amphipathic lysosomes. Leupeptin hemisulfate also has anti-inflammatory activity.
- $47
Size
QTY
CitedSelect Batch
Purity:99.19%
Contact us for more batch information
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.Product Introduction
Bioactivity
Chemical Properties
| Description | JNJ-10311795 (RWJ-355871) is a potent dual inhibitor of neutrophil elastase (Ki = 38 nM) and mast cell chymase (Ki = 2.3 nM) with significant anti-inflammatory activity, useful for studying pneumonia. |
| Targets&IC50 | Cathepsin G:82 nM |
| In vitro | JNJ-10311795 is a novel effective dual inhibitor of neutrophil cathepsin G (K (i) = 38 nM, IC50 = 82 nM) and mast cell rennet (K (i) = 2.3 nM). [1] |
| In vivo | In a rat model of inflammation, JNJ-10311795 (0.5 mg/kg intravenously) was administered 30 minutes before glycogen therapy, followed by 10 mg/kg/h intravenous infusion for 4.5 hours (total dose = 45.5 mg/kg). The increase in myeloperoxidase was reduced by 50% (neutrophil counts were reduced by 50%). [1] |
| Alias | RWJ-355871, RWJ355871, JNJ10311795 |
| Molecular Weight | 670.69 |
| Formula | C40H35N2O6P |
| Cas No. | 518062-14-1 |
| Smiles | O=C(C=1C=CC=2C=CC=CC2C1)N3CCC(N(C(=O)C4=CC=5C=CC=CC5C=C4C(=O)C(C6=CC=CC=7C=CC=CC76)P(=O)(O)O)C)CC3 |
| Relative Density. | 1.41 g/cm3 (Predicted) |
Storage & Solubility Information
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Keywords
Preview
Related Tags: buy JNJ-10311795 | purchase JNJ-10311795 | JNJ-10311795 cost | order JNJ-10311795 | JNJ-10311795 chemical structure | JNJ-10311795 in vivo | JNJ-10311795 in vitro | JNJ-10311795 formula | JNJ-10311795 molecular weight
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.